MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy
Author:
Affiliation:
1. Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Funder
funding associated with the work featured in this article
Publisher
Informa UK Limited
Subject
Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2001989
Reference34 articles.
1. Epidemiology of ovarian cancer: a review
2. Cancer statistics for the year 2020: An overview
3. Survival Analysis of Radiation Therapy in Ovarian Cancer: A SEER Database Analysis
4. Novel therapeutics: response and resistance in ovarian cancer
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. FOXO4 suppresses cisplatin resistance of Triple-Negative Breast Cancer by inhibiting autophagy;The American Journal of the Medical Sciences;2024-08
2. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling;EPMA Journal;2024-07-13
3. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies;ACS Omega;2024-06-18
4. The emerging roles of miRNA-mediated autophagy in ovarian cancer;Cell Death & Disease;2024-05-03
5. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3